The 92nd National Pharmaceutical Fair (Shanghai) Concludes Successfully | Zhongjie Pharmaceutical and Huamei Pharmaceutical Shine on Two Fronts, Achieving Remarkable Results in Investor Attraction
2026-05-18
From May 13 to 15, 2026, the 92nd National Pharmaceutical Fair (PHARMCHINA) successfully concluded at the Shanghai National Exhibition and Convention Center. Henan Zhongjie Pharmaceutical and Henan Huamei Pharmaceutical jointly participated in the event, centering on the theme “Resuming Production, Reinvigorating Innovation, and Upgrading Product Performance,” and innovatively introduced a format combining pre‑fair investment promotion seminars, online live streaming, and offline… Negotiation “Three-dimensional coordinated mode,” With “The Four New: New Texture, New Look, New Luxury, New Momentum” For Showcasing the brand’s tone and focusing on its core product portfolio with targeted efforts, the company became the highlight of the exhibition and secured substantial collaborative outcomes.
Prior to the exhibition, Zhongjie Pharmaceutical, in collaboration with Huamei Pharmaceutical, hosted a 2026 Investment Promotion Symposium on the evening of May 12, bringing together leading national distribution channel partners and healthcare‑end‑user collaborators in Shanghai. During the event, Yao Yucai, Deputy General Manager of the marketing company, provided an in-depth overview of product capacity planning, supply‑chain assurance, new‑product market strategies, and channel‑support and promotional initiatives. Guests engaged in lively discussions on key product partnership models and regional deployment, creating a dynamic and enthusiastic atmosphere. Ultimately, several high‑quality enterprises expressed intent to collaborate and signed agreements on the spot, laying a solid foundation for the company’s participation in the upcoming exhibition.
At the exhibition, the booth was anchored by the “Four New” theme, continuing a minimalist yet sophisticated design that seamlessly integrates the brand’s identity with innovative concepts, creating a showcase platform where digital manufacturing and professional expertise are deeply intertwined. Grounded in its positioning as a manufacturer of high‑volume, everyday medicines, the company structured its presentation around a dual‑track approach—“restarted products plus a dedicated new‑product section”—highlighting core restarted offerings such as Danggui Tablets and Compound Danshen Tablets, alongside flagship and key new launches like Simethicone Emulsion, Jinbiao Yili Ke, and Qingre Jiedu Oral Liquid. Notably, Chitong Xiaoyanling Granules, Betahistine Hydrochloride Tablets, Baikexing Syrup, Indapamide Tablets, and Sodium Diclofenac Enteric‑Coated Tablets were all displayed with newly designed packaging, allowing attendees to experience firsthand the results of this packaging upgrade. The company actively sought feedback and suggestions for further refinement, gathering practical insights to inform future iterations and enhancements. Through physical product displays and detailed explanations of key technical features, the exhibit underscored both the proven efficacy and mature supply chain of the restarted products, while also showcasing the new products’ dual strengths: advanced formulation upgrades and precise alignment with specific indications, coupled with improved material quality and refined visual aesthetics.
During the exhibition, a dual‑channel approach—combining online live streaming with in‑person business discussions—was implemented with remarkable efficiency. On the ground, a dedicated sales‑development team and channel managers maintained a continuous on‑site presence, providing each visiting client with personalized one‑on‑one support. They meticulously explained product highlights, applicable use cases, and channel‑specific policies, while tailoring customized solutions to meet specific needs, thereby strengthening clients’ intent to collaborate. Simultaneously, a series of specialized live streams went live online, with hosts guiding viewers through the “Four New” exhibition booths, offering detailed insights into product manufacturing processes, quality, and clinical advantages. Interactive Q&A sessions and policy briefings further reinforced the brand’s vision and the core value of its offerings. In total, the live streams drew 3,486 professional attendees, generating 45,000 impressions, thus achieving two‑way empowerment by expanding offline customer acquisition and driving online traffic.
The National Pharmaceutical Fair serves as a premier platform for companies to showcase their strengths and forge strategic partnerships. Through a comprehensive strategy encompassing pre‑fair roundtable discussions, dual‑channel investment promotion, and the exhibition of cutting‑edge innovations, Zhongjie Pharmaceutical and Huamei Pharmaceutical have fully demonstrated their robust capabilities, expanded the market reach of their core products, and broadened their nationwide network of collaborations. Looking ahead, we will continue to deepen our commitment to the pharmaceutical sector, refine our product portfolio and services, and strengthen the synergistic effectiveness of our dual‑channel approach, delivering high‑quality products and expert services to the market and contributing to the industry’s high‑quality development.
The conclusion of this grand event marks a fresh starting point for continued collaboration. Henan Zhongjie Pharmaceutical and Henan Huamei Pharmaceutical extend their heartfelt gratitude to partners across all sectors. Moving forward, we will remain true to our original mission—“Integrity at Zhongjie, Partners Across the World”—building on product excellence as our foundation and service excellence as our support, to jointly explore untapped opportunities in the pharmaceutical market with our valued customers, and embark together on a new journey of innovative development. We look forward to our next reunion, where we will once again weave a new chapter of industry‑wide cooperation.
Real-time news
2026-01-30
Investment Hotline： +86-4001336009
Drug Vigilance Department Contact Hotline：
Address：Xinxiang South Railway Station, Xinxiang City, Henan Province
E-mail：zhongjieyaoye@126.com
Official WeChat
Official Douyin
Copyright © Henan Zhongjie Pharmaceutical Co., Ltd.
Privacy Agreement Supports IPV6 SEO